Real-World Use of Long-Acting Cabotegravir + Rilpivirine in the US: Effectiveness in the First Year

Conference Reports for NATAP

ID Week
Oct 19, -23 2022
Washington DC


Real-World Use of Long-Acting Cabotegravir + Rilpivirine in the US: Effectiveness in the First Year

	IDWeek 2022 Oct 19-22 Michael G Sension CAN Community Health, Fort Lauderdale, FL, USA